India, Oct. 30 -- Iradimed Corp. (IRMD) reported Friday higher third-quarter earnings and revenue while narrowing its full-year financial forecasts.
Company Profile
Iradimed develops MRI-compatible medical devices, including non-magnetic intravenous infusion pumps and patient vital-sign monitoring systems.
Third Quarter FY26 Financial Highlights
For the quarter ended September 30, net income increased 17% to $6.51 million from $5.60 million. Diluted earnings per share rose to $0.51 from $0.43.
Adjusted net income climbed to $7.12 million, or $0.55 per share, from $6.10 million, or $0.47 per share.
Revenue advanced 14% to $24.20 million from $21.20 million. Infusion pump sales increased to $8.69 million from $8.33 million, while patien...